A National Cancer Institute-designated Comprehensive Cancer Center

Make an appointment: 800-826-HOPE
Center for Applied Technology Development Bookmark and Share

Sylvia R. and Isador A. Deutch Center for Applied Technology Development

City of Hope conducts basic research that produces valuable intellectual property, which is translated into new products, new businesses and new jobs.
 
The Sylvia R. and Isador A. Deutch Center for Applied Technology Development (CATD) offers broad expertise in technology transfer and licensing, biologics manufacturing, quality assurance and regulatory affairs. It also fosters commercial investment in the development of inventions and discoveries derived from research at City of Hope by licensing the relevant intellectual property. Through evaluation, marketing and licensing processes, CATD supports this goal by ensuring that technologies created at City of Hope are developed and commercialized for the benefit of the widest possible audience.
 
Among its many activities, CATD also hosts conferences for venture capitalists, at which City of Hope investigators present their findings to potential funding sources.
 
Our Office of Technology Licensing (OTL) actively pursues patent protection for new inventions devised by its investigators deemed of commercial importance. Further, the OTL licenses intellectual property (IP) via Internet marketing, targeted marketing and inquiries by outside interested parties.
 
The Center for Biomedicine & Genetics (CBG) is a premier academic facility specializing in rapid production of pharmaceutical-grade materials. CBG invites collaborators from other institutions and biopharmaceutical companies to test promising new therapeutics, and supports phase I and II clinical trials at City of Hope.
 
The Office of IND Development and Regulatory Affairs helps campus investigators interact with governmental regulatory agencies and remain in compliance with United States Food and Drug Administration requirements.
 
City of Hope is a designated Production Assistance for Cellular Therapies (PACT) facility. For additional information about this program, click on the link: www.pactgroup.net/
 
Partners and Contributors
City of Hope is deeply grateful to our partners whose contributions have made the  Center for Biomedicine & Genetics possible. In particular, we would like to thank the National Office Products Industry . In recognition of their generous gift to Center for Biomedicine and Genetics (CBG), the first floor of the CBG facility is named the Sylvia R. and Isador A. Deutch Center for Applied Technology Development.
 

Center for Applied Technology Development Staff

Center for Applied Technology Development

Sylvia R. and Isador A. Deutch Center for Applied Technology Development

City of Hope conducts basic research that produces valuable intellectual property, which is translated into new products, new businesses and new jobs.
 
The Sylvia R. and Isador A. Deutch Center for Applied Technology Development (CATD) offers broad expertise in technology transfer and licensing, biologics manufacturing, quality assurance and regulatory affairs. It also fosters commercial investment in the development of inventions and discoveries derived from research at City of Hope by licensing the relevant intellectual property. Through evaluation, marketing and licensing processes, CATD supports this goal by ensuring that technologies created at City of Hope are developed and commercialized for the benefit of the widest possible audience.
 
Among its many activities, CATD also hosts conferences for venture capitalists, at which City of Hope investigators present their findings to potential funding sources.
 
Our Office of Technology Licensing (OTL) actively pursues patent protection for new inventions devised by its investigators deemed of commercial importance. Further, the OTL licenses intellectual property (IP) via Internet marketing, targeted marketing and inquiries by outside interested parties.
 
The Center for Biomedicine & Genetics (CBG) is a premier academic facility specializing in rapid production of pharmaceutical-grade materials. CBG invites collaborators from other institutions and biopharmaceutical companies to test promising new therapeutics, and supports phase I and II clinical trials at City of Hope.
 
The Office of IND Development and Regulatory Affairs helps campus investigators interact with governmental regulatory agencies and remain in compliance with United States Food and Drug Administration requirements.
 
City of Hope is a designated Production Assistance for Cellular Therapies (PACT) facility. For additional information about this program, click on the link: www.pactgroup.net/
 
Partners and Contributors
City of Hope is deeply grateful to our partners whose contributions have made the  Center for Biomedicine & Genetics possible. In particular, we would like to thank the National Office Products Industry . In recognition of their generous gift to Center for Biomedicine and Genetics (CBG), the first floor of the CBG facility is named the Sylvia R. and Isador A. Deutch Center for Applied Technology Development.
 

Meet Our Staff

Center for Applied Technology Development Staff

Contact Us
For inquiries concerning the CBG manufacturing facility and collaborative opportunities please contact:
 
Larry A. Couture, Ph.D. or
David Hsu, Ph.D.
Center for Applied Technology Development
City of Hope
1500 E. Duarte Road
Duarte, CA 91010
626-256-8728
Center for Applied Technology Development (CATD)
The Sylvia R. and Isador A. Deutch Center for Applied Technology Development (CATD) offers broad expertise in technology transfer and licensing, biologics manufacturing, quality assurance and regulatory affairs.

Beckman Research Institute of City of Hope is internationally  recognized for its innovative biomedical research.
City of Hope is one of only 41 Comprehensive Cancer Centers in the country, the highest designation awarded by the National Cancer Institute to institutions that lead the way in cancer research, treatment, prevention and professional education.
Support Our Research
By giving to City of Hope, you support breakthrough discoveries in laboratory research that translate into lifesaving treatments for patients with cancer and other serious diseases.
 
 
 
 
Learn more about City of Hope's institutional distinctions, breakthrough innovations and collaborations.


NEWS & UPDATES
  • The outlook and length of survival has not changed much in the past 25 years for patients suffering from an aggressive form of pancreatic cancer known as pancreatic ductal adenocarcinoma (PDAC). These patients still have few options for therapy; currently available therapies are generally toxic and do not incre...
  • “With bladder cancer, the majority of patients that I see can be cured,” said urologist Kevin Chan, M.D., head of reconstructive urology at City of Hope. “The challenge is to get patients the same quality of life that they had before surgery.” To meet this challenge, Chan and the urologic team at City of Hope [...
  • Already pioneers in the use of immunotherapy, City of Hope researchers are now testing the bold approach to cancer treatment against one of medicine’s biggest challenges: brain cancer. This month, they will launch a clinical trial using patients’ own modified T cells to fight advanced brain tumors. One of but a...
  • Brain cancer may be one of the most-frightening diagnoses people can receive, striking at the very center of who we are as individuals. Further, it often develops over time, causing no symptoms until it’s already advanced. Listen to City of Hope Radio as Behnam Badie, M.D., director of the Brain Tumor Pro...
  • The whole is greater than the sum of its parts. It takes a village. No man is an island. Choose your aphorism: It’s a simple truth that collaboration usually is better than isolation. That’s especially true when you’re trying to introduce healthful habits and deliver health care to people at risk of disease and...
  • When Maryland Governor Larry Hogan announced earlier this week that he has the most common form of non-Hodgkin lymphoma, he was giving voice to the experience of more than 71,000 Americans each year. The announcement came with Hogan’s promise to stay in office while undergoing aggressive treatment for the...
  • The spine can be affected by many different kinds of tumors. Malignant, or cancerous, tumors can arise within the spine itself. Secondary spinal tumors, which are actually much more common, begin as cancers in another part of the body, such as the breast and prostate, and then spread, or metastasize, to the spi...
  • Although most cancer occurs in older adults, the bulk of cancer research doesn’t focus on this vulnerable and fast-growing population. City of Hope and its Cancer and Aging Research Team aim to change that, and they’re getting a significant boost from Professional Practice Leader Peggy Burhenn, R.N....
  • Liz Graef-Larcher’s first brain tumor was discovered by accident six years ago. The then-48-year-old with a long history of sinus problems and headaches had been sent for an MRI, and the scan found a lesion in her brain called a meningioma – a tumor that arises in the meninges, the layers of tissue that cover a...
  • The colon and rectum are parts of the body’s gastrointestinal system, also called the digestive tract. After food is digested in the stomach and nutrients are absorbed in the small intestine, the remaining material moves down into the lower large intestine (colon) where water and nutrients are absorbed. The low...
  • If there is one truism about hospital stays it is that patients want to get out. For many, however, the joy of being discharged is tempered by the unexpected challenges that recovery in a new setting may pose. Even with professional help, the quality of care and treatment that patients receive at City of Hope [...
  • Jana Portnow, M.D., associate director of the Brain Tumor Program at City of Hope, didn’t expect to specialize in treating brain tumors. But, early in her career, she undertook a year of research on pain management and palliative care and, in that program, got to know many patients with brain tumors. After that...
  • Ask any patient: Nurses are as pivotal in their care as doctors. They answer the call of a patient in the middle of the night, they hold the patient’s hand as he or she takes on yet another round of treatment and, in the best-case scenario, they wave goodbye as the patient leaves the hospital, […]
  • Many oncologists, not to mention their patients, might think that there’s no place for mathematical analysis in the treatment of cancer. They might think that all treatment decisions are based on unique factors affecting individual patients, with no connection to other patients and their treatment regimen...
  • Within three days in 2007, Stephanie Hosford, then 37, learned that she was pregnant with her long-awaited second child – and that she had triple-negative breast cancer. Soon afterward, Hosford discovered that she and her husband, Grant, had been approved to adopt a little girl from China.  After encountering m...